Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Fidanacogene Elaparvovec for Hemophilia B - A Multiyear Follow-up Study.
Journal: The New England journal of medicine
Published: April 16, 2025
Recurrence of Retinopathy of Prematurity Following Anti-vascular Endothelial Growth Factor (Anti-VEGF) Therapy: A Systematic Review and Meta-Analysis.
Journal: Cureus
Published: November 08, 2024
Distribution and predictors of haemophilia-related costs in the United Kingdom: analysis of the CHESS I and CHESS II burden of illness studies.
Journal: BMC health services research
Published: May 09, 2024
Global seroprevalence of neutralizing antibodies against adeno-associated virus serotypes used for human gene therapies.
Journal: Molecular therapy. Methods & clinical development
Published: August 28, 2023
Understanding AAV vector immunogenicity: from particle to patient.
Journal: Theranostics
Published: August 22, 2023
Nonacog Alfa for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Patients with Moderately Severe or Severe Hemophilia B in India.
Journal: Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion
Published: June 01, 2022
Moroctocog Alfa (AF-CC) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Patients with Hemophilia A in India.
Journal: Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion
Published: June 01, 2022
Real-world outcomes associated with standard half-life and extended half-life factor replacement products for treatment of haemophilia A and B.
Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
Published: April 10, 2020
Real-World Analysis of Dispensed International Units of Coagulation Factor VIII and Resultant Expenditures for Hemophilia A Patients: A Comparison Between Standard Half-Life and Extended Half-Life Products.
Journal: Managed care (Langhorne, Pa.)
Published: October 13, 2018
Comparison of Different Remission and Low Disease Definitions in Psoriatic Arthritis and Evaluation of Their Prognostic Value.
Journal: The Journal of rheumatology
Published: June 28, 2018
Real-World Analysis of Dispensed IUs of Coagulation Factor IX and Resultant Expenditures in Hemophilia B Patients Receiving Standard Half-Life Versus Extended Half-Life Products and Those Switching from Standard Half-Life to Extended Half-Life Products.
Journal: Journal of managed care & specialty pharmacy
Published: January 25, 2018
Incidence of new cardiovascular events in patients with and without peripheral arterial disease seen in a vascular surgery clinic.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: February 28, 2012
Last Updated: 09/26/2026